Back to RecallTracker
Health Canada Health products

NAT-Bendamustine: Discoloration

Issued December 6, 2022
Issue
The colour is out of specification in the affected lot(s).
Hazard description
Product quality
What to do
Verify if your product is affected. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
NAT-Bendamustine 100 mg/vial
Reference
ID
RA-72343